Nirsevimab Might Top Maternal Vax for Infants’ RSV Protection

(MedPage Today) — Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than those whose mothers got…